Arthrosamid is a polyacrylamide hydrogel developed by Contura International Ltd. as a long-lasting intra-articular injection, approved in Europe to treat knee osteoarthritis (OA). The treatment has the potential to change the present care pathway for managing OA, which affects around 8,6 million people in Italy1…current treatments are not long-lasting or involve invasive knee replacement surgery. Despite a large suffering population, there has been very little innovation in the range of OA treatments on offer to help patients – until now.

Hyaluronic Acid: A Promising Path for Managing Knee Osteoarthritis and Supporting Cartilage Health
Discover how hyaluronic acid injections are transforming knee osteoarthritis care. This innovative treatment not only relieves pain and improves joint mobility but also helps protect and potentially repair cartilage. Unlike traditional pain management therapies, hyaluronic acid restores the joint’s natural lubrication and cushioning, offering safe and lasting relief for people with osteoarthritis. Clinical research highlights low risk of side effects and sustained benefits, making hyaluronic acid a vital option for managing knee OA and delaying invasive surgery. Learn why hyaluronic acid is becoming a key player in the future of osteoarthritis treatment.